Assessment of microalbuminuria and glycated hemoglobin in type 2 diabetes mellitus complications

Asian Pacific Journal of Tropical Disease

Volumn 1, Issue 3, 2011, Pages 203-205

  Idogun, E S ^a   Kasia, B E ^b  

^a UNIVERSITY OF BENIN   (Nigeria)

^b DELTA STATE UNIVERSITY   (Nigeria)

Author keywords

Albumin; Albumin creatinine ratio; Creatinine; Diabetes mellitus complications; Diabetic nephropathy; Fasting plasma glucose; Glycated haemoglobin; Glycemic control; Hypertensive diabetes mellitus; Microalbuminuria; Normotensive diabetes mellitus; Regular screening; Type 2 DM

Indexed keywords

ALBUMIN; CREATININE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 80054868026     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(11)60028-5     Document Type: Article

References (14)

1. American Diabetes Association Report on the expert committee on the diagnosis and classification of DM: clinical practice recommendations. Diabetes Care 2000, 21(Suppl 11):S5-S19.
2. Perrin NE, Torbjornsdotter T, Jaremko GA, Berg UB Risk markers of future micro albuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetic patients. Pediatr Diabetes 2010, 11(5):305-313.
3. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosious FC Mechanism of glomerulosclorosis in diabetic nephropathy. Diabetes 2008, 57:1439-1445.
4. Roestenberg P Diabetes nephropathy and the pathogenic role of growth factors [Accessed on 22 Jan, 2007]. http://www.NIER.
5. Stolar M Glycaemic control and complications in types 2 diabetes mellitus. Am J Med 2010, 123(3):S3-S11.
6. Redon J Measurement of micro albuminuria-what the nephrologists should know. Nephrol Dial Transplant 2006, 21(3):573-576.
7. Vergouwe Y, Soedamah-Muthu SS, Zgibor J, Chaturredi N, Forsblom C, Snell-Bergeon JK, et al. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia 2010, 53:254-262.
8. Ofoegbu EN, Oli JM, Igweh JC Body composition of Nigerian diabetics using Bioimpedence analysis. Niger J Health Biomed Sci 2004, 3(1):37-39.
9. Braham D, Trinder P An improved colour reagent for the determination of blood glucose by glucoseoxidasesystem. Analyst 1972, 97:142-145.
10. Nuttal FQ. Glycohemoglobin HbA1 assay, fast ion-exchange resin separation method. Manual of analysis human laboratories. Wiesbaden: 1998, p. 1475-1480.
11. Lowry OH, Rosebrough NJ, Randall RJ Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
12. Gary LM, Miller WG, Josef C, James F, Neil G, Tom G, et al. Recommendation for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006, 52:5-18.
13. Amanda IA, Richard TS, Sue Em, Rudy WB, Carole AC, Rury RH Development and pogression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS64). Kidney Int 2003, 63:225-232.
14. Genuth S Insight from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract 2006, 12:34-41.